benefix 250 iu powder and solution for solution for injectio
nonacog alfa - powder and solution for solution for injectio - 250 iu - nonacog alfa
benefix 500 iu powder and solvent for solution for injection
nonacog alfa - powder and solvent for solution for injection - 500 iu - nonacog alfa
benefix 1000 ui polvo y disolvente para solución inyectable
pfizer europe ma eeig - nonacog alfa (factor ix recombinante) - nonacog alfa (factor ix recombinante)....1000 ui / cloruro de sodio al 0.234 %....11,93 mg
idelvion
csl behring (nz) ltd - albutrepenonacog alfa 1000 [iu]; ; - powder for injection - 1000 iu - active: albutrepenonacog alfa 1000 [iu] excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.
idelvion
csl behring (nz) ltd - albutrepenonacog alfa 2000 [iu]; ; - powder for injection - 2000 iu - active: albutrepenonacog alfa 2000 [iu] excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.
idelvion
csl behring (nz) ltd - albutrepenonacog alfa 250 [iu]; ; - powder for injection - 250 iu - active: albutrepenonacog alfa 250 [iu] excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.
idelvion
csl behring (nz) ltd - albutrepenonacog alfa 500 [iu]; ; - powder for injection - 500 iu - active: albutrepenonacog alfa 500 [iu] excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.
rixubis kit
takeda canada inc - nonacog gamma - kit - 250unit - nonacog gamma 250unit - hemostatics
rixubis kit
takeda canada inc - nonacog gamma - kit - 500unit - nonacog gamma 500unit - hemostatics
rixubis kit
takeda canada inc - nonacog gamma - kit - 1000unit - nonacog gamma 1000unit - hemostatics